Lab Testing in Patients on Immunomodulators Falls Short
Review found that fewer than 60% of patients with chronic inflammatory skin diseases underwent recommended testing before starting systemic immunomodulator treatment.
Source: medscape.com
Stay updated with breaking news from Denys Shay. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Review found that fewer than 60% of patients with chronic inflammatory skin diseases underwent recommended testing before starting systemic immunomodulator treatment.
Researchers found that surgical patients with a diagnosed cannabis use disorder more often required advanced postprocedural health care — such as admission to an intensive care unit — compared to non-users.